Development Scientist III, Viral Vector Analytical Development
AstraZeneca
About this role
A Development Scientist III in Viral Vector Analytical Development at Alexion contributes to the advancement of the genomic medicine portfolio by supporting analytical capabilities for recombinant AAV viral vectors. The role sits within the Genomic Medicine organization at Alexion and is positioned in a lab-focused R&D environment that interfaces with development and regulatory functions. It involves working on innovative therapies within a collaborative, science-driven company culture.
Skills
Qualifications
About AstraZeneca
astrazeneca.comDigital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
About AstraZeneca
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for AstraZeneca.
Salary
$138k – $208k
per year
More jobs at AstraZeneca
Similar Jobs
Scientist, Viral Vector Analytical Development
Eurofins
Principal Scientist, Analytical Development - Gene Therapy
Eli Lilly and Company
Scientist, Viral Vector Downstream Process Development
Eurofins
Viral Vector Core Director - Open Rank
Trinity College
Global marketing manager, viral vectors
Cepheid
Sr. Scientist - Viral Vector Expression (Biotechnology Discovery Research)
Eli Lilly and Company